4D Molecular Therapeutics Inc
NASDAQ:FDMT 3:59:54 PM EDT
| Market Cap (Intraday) | 868.74M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $33.79 |
| 50-Day MA | $29.77 |
| 200-Day MA | $34.90 |
4D Molecular Therapeutics Inc Stock, NASDAQ:FDMT
5858 Horton Street, Suite 455, Emeryville, California 94608
United States of America
Phone: +1.510.505.2680
Number of Employees: 83
Description
4D Molecular Therapeutics, Inc. engages in the design, development, and commercialization of transformative gene therapeutic products for serious unmet medical conditions. It offers products for optalmology, cardiology, and pulmonology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.